171 related articles for article (PubMed ID: 32829304)
1. Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study.
Babiuch A; Wykoff CC; Hach J; Srivastava S; Talcott KE; Yu HJ; Nittala M; Sadda S; Ip MS; Le T; Hu M; Reese J; Ehlers JP
Br J Ophthalmol; 2021 Aug; 105(8):1111-1115. PubMed ID: 32829304
[TBL] [Abstract][Full Text] [Related]
2. RETINAL LEAKAGE INDEX DYNAMICS ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY IN EYES TREATED WITH INTRAVITREAL AFLIBERCEPT FOR PROLIFERATIVE DIABETIC RETINOPATHY IN THE RECOVERY STUDY.
Babiuch AS; Wykoff CC; Srivastava SK; Talcott K; Zhou B; Hach J; Hu M; Reese JL; Ehlers JP
Retina; 2020 Nov; 40(11):2175-2183. PubMed ID: 31917731
[TBL] [Abstract][Full Text] [Related]
3. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.
Figueiredo N; Srivastava SK; Singh RP; Babiuch A; Sharma S; Rachitskaya A; Talcott K; Reese J; Hu M; Ehlers JP
Ophthalmol Retina; 2020 Feb; 4(2):154-163. PubMed ID: 31757691
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-based assessment of ultra-widefield leakage patterns and vessel network architecture in the PERMEATE study: insights into treatment durability.
Prasanna P; Bobba V; Figueiredo N; Sevgi DD; Lu C; Braman N; Alilou M; Sharma S; Srivastava SK; Madabhushi A; Ehlers JP
Br J Ophthalmol; 2021 Aug; 105(8):1155-1160. PubMed ID: 32816791
[TBL] [Abstract][Full Text] [Related]
6. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Quantitative Ultrawidefield Angiographic Features in Diabetic Retinopathy Treated with Aflibercept from the Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement Trial.
Kalra G; Wykoff C; Martin A; Srivastava SK; Reese J; Ehlers JP
Ophthalmol Retina; 2024 Feb; 8(2):116-125. PubMed ID: 37696393
[TBL] [Abstract][Full Text] [Related]
8. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Widefield Fluorescein Angiography as a Biomarker for Response to Switch in Therapy in Persistent DME.
Bahrami B; Hong T; Peto T; Chang A
Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):771-778. PubMed ID: 31877222
[TBL] [Abstract][Full Text] [Related]
10. Effect of Aflibercept on Diabetic Retinopathy Severity and Visual Function in the RECOVERY Study for Proliferative Diabetic Retinopathy.
Alagorie AR; Velaga S; Nittala MG; Yu HJ; Wykoff CC; Sadda SR
Ophthalmol Retina; 2021 May; 5(5):409-419. PubMed ID: 32882447
[TBL] [Abstract][Full Text] [Related]
11. Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ; Ehlers JP; Sevgi DD; Hach J; O'Connell M; Reese JL; Srivastava SK; Wykoff CC
Am J Ophthalmol; 2021 Jun; 226():126-136. PubMed ID: 33529593
[TBL] [Abstract][Full Text] [Related]
12. The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept.
Babiuch AS; Wykoff CC; Yordi S; Yu H; Srivastava SK; Hu M; Le TK; Lunasco L; Reese J; Nittala MG; Sadda SR; Ehlers JP
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834478
[TBL] [Abstract][Full Text] [Related]
13. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis--potential role as biomarker of response to ranibizumab treatment.
Leicht SF; Kernt M; Neubauer A; Wolf A; Oliveira CM; Ulbig M; Haritoglou C
Ophthalmologica; 2014; 231(4):198-203. PubMed ID: 24662930
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.
Wykoff CC; Nittala MG; Zhou B; Fan W; Velaga SB; Lampen SIR; Rusakevich AM; Ehlers JP; Babiuch A; Brown DM; Ip MS; Sadda SR;
Ophthalmol Retina; 2019 Dec; 3(12):1076-1086. PubMed ID: 31542339
[TBL] [Abstract][Full Text] [Related]
15. NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study.
Fan W; Nittala MG; Wykoff CC; Brown DM; Uji A; Hemert JV; Fleming A; Robertson G; Sadda SR; Ip M
Retina; 2022 Mar; 42(3):426-433. PubMed ID: 34803132
[TBL] [Abstract][Full Text] [Related]
16. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
17. Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies.
Staurenghi G; Feltgen N; Arnold JJ; Katz TA; Metzig C; Lu C; Holz FG;
Br J Ophthalmol; 2018 Jul; 102(7):954-958. PubMed ID: 29051325
[TBL] [Abstract][Full Text] [Related]
18. Repeatability of automated leakage quantification and microaneurysm identification utilising an analysis platform for ultra-widefield fluorescein angiography.
Jiang A; Srivastava S; Figueiredo N; Babiuch A; Hu M; Reese J; Ehlers JP
Br J Ophthalmol; 2020 Apr; 104(4):500-503. PubMed ID: 31320384
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count.
Ehlers JP; Jiang AC; Boss JD; Hu M; Figueiredo N; Babiuch A; Talcott K; Sharma S; Hach J; Le T; Rogozinski A; Lunasco L; Reese JL; Srivastava SK
Ophthalmology; 2019 Nov; 126(11):1527-1532. PubMed ID: 31383482
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.
Nicholson L; Crosby-Nwaobi R; Vasconcelos JC; Prevost AT; Ramu J; Riddell A; Bainbridge JW; Hykin PG; Sivaprasad S
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4277-4284. PubMed ID: 30372756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
